glp-1 receptor agonists for type 2 diabetes Trends in the Development of Understanding GLP-1 receptor agonists and
Description
The same applies to anifrolumab (Saphnelo), voclosporin (Lupkynis), and rituximab, all of which are used in various lupus presentations
Women who are experiencing patterned thinning, distinct from diffuse shedding, during GLP-1 therapy should discuss this hormonal mechanism with their dermatologist
This is not a randomized trial, of course
Patients are typically instructed by their clinician or dispensing pharmacy on how to prepare and administer each dose
doi: 10.1007/s00125-004-1380-0
Advances in Therapy 4118431859
